NASDAQ:ALEC

Alector (ALEC) Stock Price, News & Analysis

Alector logo
$2.57 +0.01 (+0.39%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$2.60 +0.03 (+1.05%)
As of 07:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Alector Stock (NASDAQ:ALEC)

Advanced

Key Stats

Today's Range
$2.51
▼
$2.74
50-Day Range
$1.81
▼
$2.63
52-Week Range
$1.09
▼
$2.84
Volume
2.13 million shs
Average Volume
1.97 million shs
Market Capitalization
$382.61 million
P/E Ratio
7.34
Dividend Yield
N/A
Price Target
$5.10
Consensus Rating
Hold

Company Overview

Alector, Inc. is a biotechnology company based in South San Francisco, California, that develops investigational therapies for neurodegenerative diseases. Its research focuses on the role of the immune system in the brain and how immune pathways may be used to address disease processes.

The company’s approach draws on human genetics and immunology to identify potential therapeutic targets. Its research has included programs targeting progranulin and TREM2, proteins associated with brain health and neurodegenerative disease.

Alector’s work has centered on antibody-based drug candidates and clinical development rather than marketed medicines. The company has no approved products; its investigational programs are intended to address conditions such as frontotemporal dementia and other neurodegenerative disorders.

AI Generated. May Contain Errors.

Alector Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

ALEC MarketRank™: 
4.640755439985 of 5 stars

Alector scored higher than 93% of companies evaluated by MarketBeat, and ranked 43rd out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alector has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 1 strong buy rating, 3 buy ratings, 1 hold rating, and 2 sell ratings.

  • Upside Potential

    Alector has a consensus price target of $5.10, representing about 98.4% upside from its current price of $2.57.

  • Amount of Analyst Coverage

    Alector has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Alector's stock forecast and price target.
  • Earnings Growth

    Earnings for Alector are expected to decrease in the coming year, from $0.48 to ($0.67) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alector is 7.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alector is 7.34, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.07.

  • Price to Earnings Growth Ratio

    Alector has a PEG Ratio of 0.16. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Alector has a P/B Ratio of 3.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    8.20% of the float of Alector has been sold short.
  • Short Interest Ratio / Days to Cover

    Alector has a short interest ratio ("days to cover") of 3.62, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alector has recently decreased by 18.15%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Alector does not currently pay a dividend.

  • Dividend Growth

    Alector does not have a long track record of dividend growth.

  • News Sentiment

    Alector has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Alector this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for ALEC on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alector insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $295,633.00 in company stock.

  • Percentage Held by Insiders

    8.30% of the stock of Alector is held by insiders.

  • Percentage Held by Institutions

    85.83% of the stock of Alector is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Alector's insider trading history.
Receive ALEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALEC Stock News Headlines

Alector (NASDAQ:ALEC) Research Coverage Started at Wells Fargo & Company
Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
Earnings Estimates Rising for Alector (ALEC): Will It Gain?
Alector (NASDAQ:ALEC) Research Coverage Started at HC Wainwright
See More Headlines

ALEC Stock Analysis - Frequently Asked Questions

Alector's stock was trading at $1.56 at the beginning of 2026. Since then, ALEC shares have increased by 64.7% and is now trading at $2.57.

Alector, Inc. (NASDAQ:ALEC) posted its quarterly earnings data on Thursday, November, 5th. The company reported $1.11 earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $1.34. The firm had revenue of $162.87 million for the quarter, compared to analyst estimates of $2.19 million. Alector had a net margin of 23.87% and a trailing twelve-month return on equity of 112.21%.

Alector subsidiaries include these companies: Alector LLC.

Alector (ALEC) raised $176 million in an initial public offering (IPO) on Thursday, February 7th 2019. The company issued 9,250,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

Top institutional shareholders of Alector include State Street Corp (1.64%), Marshall Wace LLP (0.65%), Goldman Sachs Group Inc. (0.53%) and Utah Retirement Systems (0.12%). Insiders that own company stock include Arnon Rosenthal, Sara Kenkare-Mitra, Neil Lindsay Berkley, Marc Grasso, Gary Romano, Grace Wong-Sarad, Kristine Yaffe and Paula Hammond.
View institutional ownership trends
.

Shares of ALEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alector investors own include Editas Medicine (EDIT), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Gossamer Bio (GOSS), Aktis Oncology (AKTS), Precision BioSciences (DTIL) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/05/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ALEC
CIK
1653087
Fax
N/A
Employees
103
Year Founded
2013

Price Target and Rating

High Price Target
$8.00
Low Price Target
$1.50
Potential Upside/Downside
+98.4%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.35
Trailing P/E Ratio
7.34
Forward P/E Ratio
N/A
P/E Growth
0.16
Net Income
-$142.93 million
Net Margins
23.87%
Pretax Margin
24.08%
Return on Equity
112.21%
Return on Assets
18.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.10
Quick Ratio
4.10

Sales & Book Value

Annual Sales
$173.47 million
Price / Sales
2.21
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.78 per share
Price / Book
3.29

Miscellaneous

Outstanding Shares
148,877,000
Free Float
136,520,000
Market Cap
$382.61 million
Optionable
Optionable
Beta
0.61

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:ALEC) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners